Kedrion Biopharma

RYPLAZIM

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / RYPLAZIM – J2998

Manufacturer:

Kedrion Biopharma

Name:

RYPLAZIM

HCPCS Code Descriptor:

Injection, plasminogen, human-tvmh, 1 mg

Category:

J Code

HCPCS:

J2998

NDC(s):

70573-0099-01, 70573-0099-02

Primary Type:

Hematology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

70573-0099-01

Please contact us regarding potential compendia errors/discrepancies

About:

RYPLAZIM is a Hematology drug manufactured by Kedrion Biopharma and administered via the Intravenous route of administration. The J Code: J2998 is aligned to the drug RYPLAZIM.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

7/1/22

HCPCS Effective Date:

7/1/22

HCPCS Short Description:

Inj plasminogen tvmh 1mg

Billing and Coding Guide:

https://www.ryplazim.com/pdf/ryplazim-billing-and-coding-guide.pdf

Patient Assistance:

https://www.ryplazim.com/support/

RYPLAZIM - J2998